Want to keep up-to-date?
Gilbert's own Scott Fleming talks about Gilbert's Smart Precision Inhaler and why the time is ripe for this innovation.
Gilbert looks forward to attending the annual DDL (Drug Delivery to the Lungs) conference in Edinburgh from Dec 11th-13th. This year DDL is celebrating its 35th anniversary and this promises […]
The Gilbert team looks forward to attending the International Conference on “Exploring the Future of Inhalation Drug Delivery“, organized by the University of Parma and supported by the Galenus Foundation, […]
The Gilbert team looks forward to attending the European Respiratory Society (ERS) in Vienna from Sept 7th-11th. Our special interest is to catch up on the latest research in inhaled […]
Please meet our new team member Hans Kersbergen! Read all about his position as System Architect and why he joined the Gilbert team.
Gilbert is open for collaboration to redefine treatments for lung patients with an initial interest in improving inhaled anti-infective treatments. Following our recent introduction at the SMI.London Conference on June […]
The Gilbert team will be visiting HLTH Europe 2024, coming 17-20 June in Amsterdam. We look forward to connect with pharma and biotech decision makers to redefine treatment for lung […]
We have changed our company brand from Gilbert Technologies to just ..... Gilbert! This change reflects an underlying change in our legal structure, where Gilbert Innovation, Gilbert Therapeutics and Gilbert […]
The Gilbert team looks forward to exhibiting at SMI London on June 25th. Join us at this 2nd Soft Mist Inhaler conference and learn to make, develop, use, file and […]
Gilbert is a proud sponsor of the 7th European Symposium on Electrohydrodynamic Atomization and Electrospinning 2024. This year ESEE2024 is taking place in Leeuwarden, The Netherlands from April 24-26. We […]
Gilbert is hiring a System Architect based at our office on the High Tech Campus Eindhoven. At Gilbert we are developing a next-generation soft mist inhaler with a revolutionary new […]
The Gerard & Anton Awards ceremony highlights 10 promising start-ups in the Brainport Eindhoven region each year. Gilbert has been selected a one of the 2023 winners. Click here for […]
Dutch MedTech Company Gilbert Raises €7 Million Series A to Redefine Treatment for Lung Patients. Eindhoven, The Netherlands, June 7 2023 – Gilbert, today announced the completion of its €7 […]
Engineering the inhaler of the future What is the most important success factor to bring a medical technology from lab bench to hospital? At the High Tech Campus Eindhoven Technology […]
Gilbert names Scott Fleming Chief Commercial Officer. Click here for the full press release.
Gilbert Announces George Hersbach to serve as Executive Chairman and Transition Role of CEO to Current COO Maurits Huigen. Click here for the full press release.
Interview with our COO Maurits Huigen after the nomination of Gilbert as one of the promising respiratory device solution providers by Medical Tech Outlook Magazine.
The startup company Gilbert R&D B.V., a subsidiary of Gilbert B.V., announces today that it has received funding for the development of a new generation soft mist inhalers for the […]
Belgium UCLouvain Louvain Drug Research Institute (LDRI) and Netherlands MedTech Start-up Gilbert join efforts for improved therapy for Cystic Fibrosis Patients.LDRI receives funding for the development of a long-acting PEGylated […]
MedTech Magazine, December 2018 When it comes to pulmonary drug administration and therapy adherence, it is noted that many of the commercially available inhalers such as Dry Powder Inhalers (DPIs) and […]
Let’s stay in touch!
Stay up-to-date with Gilbert’s latest news, vacancies and achievements by following us on social media.